TECHNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends June 30
BIO-TECHNE Corp
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-K on Aug 24, 2026
$72.49−0.08 (-0.11%)
Close on Oct 19, 2026
- Market cap
- $11.40B
- P/E (TTM)
- 62.5
- Dividend yield
- 0.44%
Debt
Borrowings on the balance sheet, Jun 30, 2026
Total debt
$200.00M
Long-term debt
Net debt
-$64.71M
After $264.71M of cash
Implied interest rate
3.53%
FY2026 interest ÷ average debt
Interest coverage
26.2×
FY2026 operating income ÷ interest
Total debt by fiscal year
Long-term plus current debt, USD
Bond issues
Individual notes and bonds outstanding
Bond-level data is not connected yet
Coupon, maturity and amount of each note will come from the debt footnote in Bio-Techne's annual report. Trading prices and yields need FINRA TRACE data.